Canada

Acerus Pharmaceuticals Corporation

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Herschkowitz, Samuel Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
324.12
Quantity 41,101 +18.0%
Value US$4,593,866
Herschkowitz, Samuel Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
18.49
Quantity 47,802
Value CA$2,992,368
Motz, Robert Martin Senior Officer of Issuer Officer
Transaction date
Purchase
Price
424.07
Quantity 95,997 +40.8%
Value CA$1,309,064
Motz, Robert Martin Senior Officer of Issuer Officer
Transaction date
Purchase
Price
4.53
Quantity 100 +4.3%
Value CA$453
Motz, Robert Martin Senior Officer of Issuer Officer
Transaction date
Purchase
Price
4.50
Quantity 200 +9.5%
Value CA$900
Motz, Robert Martin Senior Officer of Issuer Officer
Transaction date
Purchase
Price
4.40
Quantity 100 +5.0%
Value CA$440
Gudaitis, Edward Joseph Director of Issuer, Senior Officer of Issuer Executive Director
Transaction date
Purchase
Price
4.52
Quantity 500 +0.6%
Value CA$2,260
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-25 2022-05-25 B Purchase
Herschkowitz, Samuel

Director of Issuer

Non-Executive Director
41,101 +18.0%
324.12
US$4,593,866 		41,101 +18.0% 324.12 US$4,593,866
2022-05-12 2022-05-12 B Purchase
Herschkowitz, Samuel

Director of Issuer

Non-Executive Director
47,802
18.49
CA$2,992,368 		47,802 18.49 CA$2,992,368
2022-05-11 2022-05-11 B Purchase
Motz, Robert Martin

Senior Officer of Issuer

Officer
95,997 +40.8%
424.07
CA$1,309,064 		95,997 +40.8% 424.07 CA$1,309,064
2022-05-11 2022-05-11 B Purchase
Motz, Robert Martin

Senior Officer of Issuer

Officer
100 +4.3%
4.53
CA$453 		100 +4.3% 4.53 CA$453
2022-05-11 2022-05-11 B Purchase
Motz, Robert Martin

Senior Officer of Issuer

Officer
200 +9.5%
4.50
CA$900 		200 +9.5% 4.50 CA$900
2022-05-11 2022-05-11 B Purchase
Motz, Robert Martin

Senior Officer of Issuer

Officer
100 +5.0%
4.40
CA$440 		100 +5.0% 4.40 CA$440
2022-05-11 2022-05-11 B Purchase
Gudaitis, Edward Joseph

Director of Issuer, Senior Officer of Issuer

Executive Director
500 +0.6%
4.52
CA$2,260 		500 +0.6% 4.52 CA$2,260
Explore more

More insider trading research around Acerus Pharmaceuticals Corporation

More insider trades in Canada
Insider trading in North America